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PURPOSE: Primary care physicians often do not use spirometry to conﬁrm the diagnosis of chronic
obstructive pulmonary disease. This project was designed to see how well physicians’ impressions about
their patients’ chronic obstructive pulmonary disease severity correlate with the severity of airﬂow
obstruction measured by spirometry and to assess whether spirometry results subsequently changed the
physicians’ opinions about chronic obstructive pulmonary disease severity and treatment.
METHODS: We performed a multicenter, cross-sectional, observational study conducted in 83 primary care
clinics from across the United States. A total of 899 patients with a clinical diagnosis of chronic obstructive
pulmonary disease completed a questionnaire and spirometry testing. Physicians completed a questionnaire
and case report forms. Concordance among physician ratings, patient ratings, and spirometry results was
evaluated.
RESULTS: Physicians’ chronic obstructive pulmonary disease severity ratings before spirometry were ac-
curate for only 30% of patients with evaluable spirometry results, and disease severity in 41% of patients
was underestimated. Physicians also underestimated severity compared with patients’ self-assessment
among 42% of those with evaluable results. After spirometry, physicians changed their opinions on the
severity for 30% of patients and recommended treatment changes for 37%. Only 75% of patients performed
at least 1 high-quality spirometry test; however, the physicians’ opinions and treatment decisions were
similar regardless of suboptimal test results.
CONCLUSIONS: Without performing spirometry, physicians are likely to underestimate their patients’
chronic obstructive pulmonary disease severity or inadequately characterize their patients’ lung disease.
Spirometry changed the physicians’ clinical impressions and treatments for approximately one third of these
patients; thus, spirometry is a valuable tool for chronic obstructive pulmonary disease management in
primary care.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/)  The American Journal of Medicine (2015)
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primary care clinics is inconsistent, with the percentage who
have ever had a spirometry test ranging from 6% to 68%.5-12
Furthermore, in cross-sectional studies of patients with
a clinical diagnosis of chronic obstructive pulmonary disease
who subsequently undergo spirometry, 32% to 42% do notCLINICAL SIGNIFICANCE
 Physicians underestimated the chronic
obstructive pulmonary disease severity
of approximately half of their patients
compared with objective assessment by
spirometry.
 Physicians’ estimates of chronic
obstructive pulmonary disease severity
were less severe than their patients’ self-
assessments, indicating that primary
care physicians tend to underestimate
the impact that chronic obstructive
pulmonary disease has on their patients’
lives.
 After reviewing the spirometry, the re-
sults changed physicians’ opinions about
disease severity in approximately half of
this cohort and changed treatment in
approximately one third of this cohort.have airﬂow obstruction.8,11,13-15
Many reasons for the underuse
of spirometry in primary care have
been identiﬁed. Some are institu-
tional barriers, such as limited
access to spirometry equip-
ment,16-18 lack of staff training in
how to obtain adequate tests,19,20
and limited physician training in
interpreting the results.20,21 Others
are practical limitations, such as
insufﬁcient time in overburdened
primary care clinics,17,19,20,22-24
the need for constant recalibra-
tion of the spirometer, and other
quality assurance concerns.19,20,24-29
Surveys and focus groups of pri-
mary care physicians also have
found that many simply prefer to
base the diagnosis of chronic
obstructive pulmonary disease on
signs and symptoms, which may
reﬂect a lack of understanding
of the importance of conﬁrming
the diagnosis objectively or a
sense of nihilism about chronic obstructive pulmonary
disease.16,17,20,30,31
Recent guidelines, expert opinions, and clinical studies
may create confusion or skepticism about the role of
spirometry in primary care. The US Preventative Services
Task Force conducted a comprehensive review of the role of
spirometry in screening for chronic obstructive pulmonary
disease and concluded that screening asymptomatic adults
would mostly identify persons with mild to moderate airﬂow
obstruction “who would not experience additional health
beneﬁts if labelled as having COPD”. The Task Force
recommended “Do not screen adults for COPD using
spirometry.”32-34 The Task Force’s recommendations were
based on population-based screening of asymptomatic per-
sons, but the nuances of using spirometry for screening
versus diagnostic testing are easily confused. Studies
examining the validity and effectiveness of spirometry in
primary care have reported variable results. Some programs
were generally successful26,27,35,36 while others were
disappointing,19,20,29,37-39 even when equipment and
training were provided for free. Advocacy groups, such as
the National Lung Health Education Program, continue to
promote the use of spirometry in primary care,40,41 but some
experts suggest that it is more practical to refer patients to
outside laboratories for spirometry tests.42,43 Recent chronic
obstructive pulmonary disease guidelines, including those ofthe Global Initiative for Chronic Obstructive Lung Disease
(GOLD) Committee, recommend spirometry for all patients
with suspected chronic obstructive pulmonary disease, but
they acknowledge the weak correlation between the degree
of airﬂow obstruction and the clinical outcomes.1,3,4
Few studies have examined how spirometry affects pri-
mary care physicians’ impressions
about the severity of chronic
obstructive pulmonary disease in
their patients or whether spirom-
etry results improved their de-
cisions about chronic obstructive
pulmonary disease treatment.35,44
Understanding how spirometry
affects providers’ opinions of
their patients and changes chronic
obstructive pulmonary disease
treatment could provide new
insight into the value of spirometry
in primary care and how best to
support physicians in improving
chronic obstructive pulmonary
disease diagnosis and management.
The primary aim of this study
was to examine how primary care
physicians’ subjective opinions
about the severity of chronic
obstructive pulmonary disease in
their patients compares with the
severity of airﬂow obstruction
measured by spirometry. Addi-tional aims were to assess whether spirometry results would
change the physicians’ opinions about their patients’ chronic
obstructive pulmonary disease severity and affect their
treatment, to compare how closely patients’ self-
assessments of chronic obstructive pulmonary disease
severity agree with their physicians’ assessment, and
describe clinical characteristics that are associated with
physician over- or underestimation of chronic obstructive
pulmonary disease severity compared with spirometry.MATERIAL AND METHODS
Participants and Recruitment Strategy
This is a cross-sectional clinical study of patients with
chronic obstructive pulmonary disease who were treated in
primary care practices in the United States. A total of 95
primary care physicians with clinical research experience
were recruited to participate, and 83 study investigators
enrolled at least 1 patient. Investigators identiﬁed potential
subjects in electronic records using a stratiﬁed random
sampling approach (ie, selection of each nth patient) to
ensure unbiased selection. Patients were recruited by
investigators using a scripted telephone call or mailed letter.
Patients who were aged 40 years or more with English
language ability—and diagnosed and treated for chronic
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physician’s clinic—were included in the study. Patients
were excluded if they had conditions that contraindicated
the forced expiratory maneuver or had participated in a
clinical trial within the previous 12 months.Data Collection
Data were collected by investigators during a scheduled
ofﬁce visit. During the visit, physicians recorded the
patients’ clinical history, spirometry results obtained during
the visit, severity assessments, and healthcare resource use
in a web-based case report form. Patients completed a paper
questionnaire to collect demographic and clinical charac-
teristics, healthcare resource use, and chronic obstructive
pulmonary disease-speciﬁc measures. The Clinical COPD
Questionnaire (CCQ), a 10-item chronic obstructive pul-
monary disease health status measure, and The Duke Health
Proﬁle, a 17-item general health status proﬁle measure
designed for use in primary care settings, were collected to
determine patient-reported physical, mental, and social
health.45-47 Each investigator also completed a 1-time web
survey to collect demographic and practice characteristics,
use of spirometry, and knowledge of GOLD guidelines
before initiation of patient enrollment at the site. Data were
collected between February 2012 and November 2012. This
study was approved and overseen by the Sterling Institu-
tional Review Board (Atlanta, Ga), study #3872. Informed
consent was obtained from all participants.Spirometry Procedure
Each site was provided with an electronic MicroLoop
portable spirometer and the associated Spirometry PC soft-
ware (CareFusion Corporation, San Diego, CA) for study
use. The spirometer provided an assessment of the adequacy
of the blows (ie, whether a test was good), indicated whether
a patient’s overall results met American Thoracic Society
(ATS) guidelines, and saved all test results by patient.
Following ATS guidelines, relaxed spirometry testing was
ﬁrst used to capture 3 slow vital capacity results, and then
forced spirometry testing was used to capture 3 technically
acceptable results for forced vital capacity (FVC) and forced
expiratory volume in 1 second (FEV1). Up to 8 efforts were
required from each patient to obtain up to 3 acceptable tests
according to ATS guidelines. Predicted values and the
percentage of predicted FEV1 were calculated using Na-
tional Health and Nutrition Examination Survey III refer-
ence values.
Before patient enrollment, investigators and study
personnel completed a real-time, study-speciﬁc training on
the study procedures, including standard ATS spirometry
procedures and how to use the MicroLoop spirometer, via
an online meeting platform. After enrollment of the ﬁrst 3
patients at each study site, spirometry results were sent to an
independent respiratory therapist experienced and certiﬁed
in pulmonary function testing for quality-control review.CHRONIC OBSTRUCTIVE PULMONARY DISEASE
SEVERITY
Before testing each patient, the investigator recorded a
global assessment of the patient’s chronic obstructive
pulmonary disease severity at the time of the study visit on a
5-point scale, ranging from 1 (no clinical symptoms or
disease impact) to 5 (very severe). Patients’ general
assessment of their severity at the time of the study visit was
collected on the patient questionnaire using a 5-point scale,
ranging from 1 (very mild) to 5 (very severe).
By using the spirometry test results, patients were clas-
siﬁed into chronic obstructive pulmonary disease severity
levels based on the GOLD guidelines, adding a “stage 0” for
patients who were at risk for chronic obstructive pulmonary
disease but had normal spirometry or did not have an FEV1/
FVC ratio less than 0.70. According to GOLD terminology,
the chronic obstructive pulmonary disease severity for those
with an FEV1/FVC ratio less than 0.70 was described using
the percent of predicted FEV1 stratiﬁed as follows:
 Mild COPD: FEV1 80% predicted
 Moderate COPD: FEV1 from 50% up to 80% predicted
 Severe COPD: FEV1 from 30% up to 50% predicted
 Very Severe COPD: FEV1 <30% predictedStatistical Approach
Statistical comparisons of continuous variables were made
using t tests and analysis of variance, as appropriate. Counts
and percentages were compared using chi-square analyses.
To compare agreement between the perceived severity
measures and the spirometry-based severity results, a
Cohen’s kappa coefﬁcient was used. This approach evalu-
ates disagreement between levels of severity and provides a
summary result ranging from 0 (no agreement) to 1 (perfect
agreement). All analyses used a 2-sided P value of .05 for
signiﬁcance and were performed using SAS 9.2 (SAS
Institute Inc, Cary, NC).RESULTS
Most participating physicians (63%) described their specialty
as Family Practice, and the rest described their specialty as
General Internal Medicine (Table 1). The average
participating physician had more than 2 decades of practice
experience, was in a solo or small group single-specialty
practice, and was managing a large number of patients with
chronic obstructive pulmonary disease in their clinic.
Spirometry was routinely used by the majority of these phy-
sicians (38% for all or approximately all, and 22% for most
patients with chronic obstructive pulmonary disease), largely
for the purpose of initial diagnosis, and all but 4 had some
formal training in spirometry use and interpretation. Only
11% were not familiar with current GOLD chronic obstruc-
tive pulmonary disease guidelines (data not shown).
The average study participant was aged 65.4 years, 54%
were women, 78% were non-Hispanic white, 84% had
Table 1 Investigator and Practice Characteristics and
Spirometry Experience
Physician Characteristics
Total
(N ¼ 83)
Mean SD
Years in practice 22.0 9.1
Patients with COPD currently treated by
investigator
161.5 180.7
n Col %
Investigator specialty
Family Practice 52 63
General Internal Medicine 31 37
Investigator gender
Male 73 88
Female 10 12
Practice size
Solo practice 32 39
Group practice, 5 physicians 41 49
Group practice, 6-15 physicians 9 11
Group practice, 16-30 physicians 1 1
Practice setting
Single specialty 66 80
Multispecialty group 17 20
Spirometer available in ofﬁce 69 83
Use of ofﬁce spirometry for COPD by investigator*
All or almost all 26 38
Most 15 22
Approximately half 9 13
Some 16 23
Very few or none 3 4
Investigator’s spirometry training
No training 4 5
Training during professional education 56 68
Training on speciﬁc device 48 58
General training during professional meetings 41 49
Project-speciﬁc training for other research
studies
29 35
Other 1 1
COPD ¼ chronic obstructive pulmonary disease; SD ¼ standard
deviation.
*Of investigators with spirometer available in ofﬁce.
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equivalent, and 73% had household annual incomes less
than $50,000 US dollars per year (Table 2). Most patients
were obese (43%) or overweight (29%), and only 4%
were underweight. Only 9% were never-smokers, and the
mean smoking history among former and ex-smokers was
50.1 pack-years. A history of asthma was reported by 42%
of patients but only 31% of their doctors, and among
patients who reported also having asthma, the diagnosis
occurred an average of 23 years before the study visit,
versus 10 years for their chronic obstructive pulmonary
disease diagnosis.
Even with study-speciﬁc training for all spirometry
technicians and use of state-of-the-art spirometers, 223patients (25%) were unable to perform at least 1 spirometry
that met the ATS standards for an acceptable effort and were
designated the Incomplete Spirometry group. The only sta-
tistically signiﬁcant demographic differences between these
groups were race/ethnicity (non-Hispanic white 69% in the
Incomplete Spirometry group vs 81% among the rest). Pa-
tients in the Incomplete Spirometry group also had signiﬁ-
cantly poorer heath status compared with the rest of patients,
as indicated by higher CCQ scores (Total and Functional
State) and the Duke Health Proﬁle (lower physical, mental,
and general health scores and greater anxiety, depression,
pain, and disability scores) (results not shown).
Among the 668 patients with spirometry that could be
rated for severity, the agreement between the physician’s
assessment of chronic obstructive pulmonary disease
severity and the severity as measured by spirometry was
poor, with physicians underestimating their patients’ airﬂow
obstruction in 41% of this group (Figure 1). The agreement
between patient self-assessment and spirometry severity was
only slightly better. The agreement between the doctor’s
impression of chronic obstructive pulmonary disease
severity and their patient’s self-assessment was also poor
(k ¼ 0.18). Among patients with at least 1 ATS quality test,
68% rated their chronic obstructive pulmonary disease
severity as moderate or worse, whereas before spirometry
their doctors rated 48% of this group with moderate or
worse severity (Table 3).
After reviewing each patient’s spirometry, the physicians
were asked to again rate their patients’ chronic obstructive
pulmonary disease severity (Table 3). There were
substantial changes in the ratings, more in alignment with
their patient’s self-assessment, particularly among those
with conﬁrmed airﬂow obstruction. Spirometry changed the
physician’s rating of chronic obstructive pulmonary disease
severity for 368 of the 668 patients (55%) who completed at
least 1 ATS quality spirometry, with 45% ﬁnding that their
patient’s disease was more severe than expected. Although
213 patients (32%) were found to have GOLD 0 (normal or
restrictive spirometry) or mild chronic obstructive pulmo-
nary disease (Table 2), physicians reclassiﬁed disease
severity as less severe in only 66 patients (10%) (Table 3).
Physicians were then asked directly whether the
spirometry results changed their prior assessment of the
patient’s chronic obstructive pulmonary disease severity,
and among 219 of the 668 patients (33%) the physicians
indicated that they considered their patients’ disease severity
as more severe (24%) or less severe (9%), whereas 64% said
that the spirometry results were consistent with what they
expected (Table 4). Although the spirometry quality for the
223 patients in the Incomplete Spirometry group did not
meet ATS standards, the impact on physicians’
impressions of chronic obstructive pulmonary disease
severity was still changed for 22% of this group, with
disease severity rated as more severe in 37 patients (17%)
and less severe in 12 patients (5%).
Physicians were then asked if their patients’ spirometry
results would cause them to change their chronic obstructive
Table 2 Patient Demographics and Clinical Characteristics
Total
(N ¼ 891)
ATS Spirometry
(N ¼ 668)
Incomplete Spirometry
(N ¼ 223)
Mean SD Mean SD Mean SD
Patient age 65.4 10.5 65.8 10.1 64.2 11.5
Years seeing Primary Care Physician (investigator-reported) 10.2 8.2 10.2 7.9 10.3 9.0
Patient age at COPD diagnosis (patient reported)* 55.4 14.2 55.8 14.3 54.2 13.7
Best spirometry result from site visit
FEV1 (liters) e e 1.66 0.76 e e
FVC (liters) e e 2.71 0.92 e e
%FEV1 predicted e e 60.3 23.0 e e
%FVC predicted e e 73.5 20.3 e e
n Col % n Col % n Col %
Age group
40-49 y 60 7 36 5 24 11
50-59 y 214 24 157 24 57 26
60-64 y 139 16 109 16 30 14
65-69 y 159 18 122 18 37 17
70-74 y 130 15 102 15 28 13
75-79 y 104 12 78 12 26 12
80þ y 85 10 64 10 21 9
Gender*
Male 411 46 316 47 95 43
Female 478 54 350 53 128 57
Highest education level*
Less than high school 47 5 34 5 13 6
Some high school 97 11 71 11 26 12
High school or equivalent 320 36 231 35 89 40
Some college but no degree 219 25 176 26 43 19
2-year degree 90 10 62 9 28 13
College graduate 65 7 54 8 11 5
Graduate school 50 6 37 6 13 6
Race/ethnicity*
Non-Hispanic white 694 78 540 81 154 69
Hispanic 46 5 29 4 17 8
Black or African American 103 12 68 10 35 16
Other 45 5 28 4 17 8
Household income*
<$25,000 375 44 272 43 103 48
$25,000-$49,999 251 29 181 28 70 33
$50,000-$74,999 136 16 115 18 21 10
$75,000-$99,999 42 5 31 5 11 5
>$100,000 49 6 40 6 9 4
Smoking status*
Current smoker 348 39 250 38 98 44
Former smoker 453 51 356 54 97 44
Never smoked 79 9 53 8 26 12
BMI
Underweight (<18.5) 36 4 28 4 8 4
Normal weight (18.5-24.9) 207 23 159 24 48 22
Overweight (25-29.9) 262 29 200 30 62 28
Obese (BMI 30) 386 43 281 42 105 47
Prior spirometry experience (patient-reported)*
Have not had prior spirometry test 122 14 83 12 39 18
Unknown history 43 5 24 4 19 9
Have had a prior spirometry test 723 81 559 84 164 74
ATS ¼ American Thoracic Society; BMI ¼ body mass index; COPD ¼ chronic obstructive pulmonary disease; FEV1 ¼ forced expiratory volume in 1 second;
FVC ¼ forced vital capacity; SD ¼ standard deviation.
*Items do not total 891 responses when some patients did not answer that item.
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41% 30% 29%   κ=0.11
Physician < Spirometry Physician = Spirometry Physician > Spirometry
32% 32% 35%  κ=0. 12
Paent < Spirometry Paent = Spirometry Paent > Spirometry
42% 39% 18%   κ=0. 18
Physician < Paent Physician = Paent Physician > Paent
Figure 1 COPD severity estimate by physicians (pre-test) versus spirometry. Patients* versus spirometry and physicians (pre-test)
versus patients. *A total of 668 patients with spirometry results that could be rated for severity.
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891 patients, 315 (35%) would have chronic obstructive
pulmonary disease medications added or increased, and only
20 (2%) would have their chronic obstructive pulmonary
disease medications reduced or discontinued. Again, the fact
that the spirometry quality did not meet ATS standards
appeared to have little effect on physicians’ opinions, with
the distribution of treatment changes among patients with
Incomplete Spirometry group being similar to those who
had 1 good quality effort.
We examined clinical factors associated with physician
over- or underestimation of chronic obstructive pulmonary
disease severity compared with ATS quality spirometry to
discern whether any might be clinically useful predictors
(Table 5). Disease severity was underestimated in
approximately half (48%) of men, but equally under- and
overestimated in women. Disease severity tended to be
overestimated (40%) in obese persons and underestimated
(49%-57%) in all other weight categories. Persons in
whom disease severity was underestimated also tended to
be older, non-Hispanic white, and in the middle-income
range, and to have more comorbid conditions. However,
there were no factors that were associated so strongly with
under- or overestimation of severity that they would obviate
the need for spirometry.Table 3 Patient- and Investigator-Reported Chronic Obstructive Pulm
Severity Rating
Spirometry Severity
(N ¼ 666)
Physician Estimate of S
Before Spirometry (N ¼
GOLD 0 or very mild 213 (32%)* 136 (20%)
Mild 44 (7%) 212 (32%)
Moderate 203 (30%) 199 (30%)
Severe 148 (22%) 107 (16%)
Very severe 58 (9%) 14 (2%)
n (Column %).
GOLD ¼ Global Initiative for Chronic Obstructive Lung Disease.
*Includes persons with no airﬂow obstruction (FEV1/FVC ratio 0.70).DISCUSSION
We found that primary care physicians’ subjective opinions
about their patients’ chronic obstructive pulmonary disease
severity were correlated poorly with the stage of airﬂow
obstruction measured by spirometry, with approximately
half underestimating chronic obstructive pulmonary disease
severity. The physicians’ estimates of chronic obstructive
pulmonary disease severity were less severe than their
patients’ self-assessments, indicating that physicians may
be underestimating the impact that chronic obstructive
pulmonary disease has on their patients’ lives. After
reviewing the spirometry, the results did change the physi-
cians’ opinions about disease severity in a substantial pro-
portion of patients, even if the test did not meet ATS
standards for quality. Physicians also conﬁrmed that the
spirometry results would change the chronic obstructive
pulmonary disease management of approximately one third
of the total study cohort. These results demonstrate that
spirometry has a substantial impact on physicians’ assess-
ment and treatment of chronic obstructive pulmonary
disease, and that without performing spirometry, they are
likely to misdiagnose chronic obstructive pulmonary disease
or grossly underestimate its severity.
We also found 2 important barriers that may affect the
widespread uptake of spirometry in primary care. First, onlyonary Disease Severity Compared with Spirometry
everity
668)
Patient Estimate of
Severity (N ¼ 654)
Physician Estimate of Severity
After Spirometry (N ¼ 668)
65 (10%) 54 (8%)
142 (22%) 150 (22%)
291 (45%) 245 (37%)
134 (20%) 179 (27%)
22 (3%) 40 (6%)
Table 4 Spirometry: Impact on Physician Severity Assessment and Treatment Decisions
Total
(N ¼ 891)
ATS Spirometry
(N ¼ 668)
Incomplete Spirometry
(N ¼ 223)
n Col % n Col % n Col %
Did study spirometry results alter investigator’s prior assessment of
severity?
No, the subject’s COPD severity is what was expected 573 64 427 64 146 66
No, the spirometry results were invalid/unreliable* 33 4 9 1 24 11
No, spirometry is a minor part of investigator’s assessment of COPD
severity
17 2 13 2 4 2
Yes, the investigator considers the subject’s COPD to be more severe* 194 22 157 24 37 17
Yes, the investigator considers the subject’s COPD to be less severe 74 8 62 9 12 5
Treatment changes considered on the basis of spirometry results
Initiating or adding COPD medications 240 27 188 28 52 23
Discontinuing current COPD medication(s) 15 2 14 2 1 0
Increasing dose or dose frequency of current COPD medications(s) 75 8 60 9 15 7
Decreasing dose or dose frequency of current COPD medication(s) 5 1 2 0 3 1
Adding or changing other nonpharmacologic therapy 78 9 59 9 19 9
No changes (consider the subject’s current therapy appropriate) 528 59 393 59 135 61
Don’t know/not sure* 33 4 20 3 13 6
ATS ¼ American Thoracic Society; COPD ¼ chronic obstructive pulmonary disease.
*Difference between ATS and incomplete spirometry groups signiﬁcant at P < .05.
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spirometry effort that met ATS quality standards, and only
56% could provide 3 efforts that met the reproducibility
standards. This is disappointing, especially given that 84%
of the patients had prior experience with spirometry and that
the great majority of clinics routinely performed in-ofﬁce
spirometry. This suggests that although some primary care
clinics are adept at obtaining good-quality tests, most will
ﬁnd it technically challenging, and a large proportion of
patients tested will still need to be referred for complete
pulmonary function testing. Second, among patients who
did complete at least 1 ATS quality test, 32% had restrictive
or normal spirometry, suggesting that the physicians may
not be interpreting spirometry data correctly. Although it is
still possible that these patients had chronic obstructive
pulmonary disease, additional testing is necessary to
conﬁrm the diagnosis, such as complete pulmonary function
testing including lung volume and diffusion capacity mea-
surement. Our ﬁndings seem to support the opinions of those
who suggest that although spirometry is undoubtedly
important, it might be more practical for most primary care
physicians to refer patients to pulmonary function labora-
tories, especially if the results of their ofﬁce testing are not
clearly interpretable.42,43,48
Few studies have measured the impact of spirometry
among patients with chronic obstructive pulmonary disease
who are treated in primary care clinics, but those that have
report similar ﬁndings. Yawn et al35 conducted a study
designed to assess the technical quality, accuracy of
interpretation, and impact of ofﬁce spirometry on treatment
and management decisions for patients with asthma and
chronic obstructive pulmonary disease in primary care. Atotal of 368 patients (100 diagnosed with chronic
obstructive pulmonary disease) were recruited from 12
family medicine practices across the United States. Similar
to our study, only 71% of the tests were deemed techni-
cally adequate for interpretation. Compared with lung
specialist interpretation, 30% of the physicians’ spirometry
interpretations for patients with chronic obstructive pul-
monary disease were not correct, with a report of
obstruction when no obstruction was present being the
major discordance. Changes in management were reported
for 48% of all participants in this study. The percentage of
patients with chronic obstructive pulmonary disease with
changes in management compared to those with asthma
was not provided. Other studies have demonstrated poor
agreement between physician opinions of severity and
other objective measures.13,47Study Limitations
First, we recruited primary care physicians who had an
active interest in chronic obstructive pulmonary disease and
relatively large numbers of well-established patients with
chronic obstructive pulmonary disease in their practices. We
suspect that our results would be different if physicians with
other experience and practice populations had been selected.
Another difﬁculty is that the terminology for the severity of
chronic obstructive pulmonary disease is subjective, so
when asked about their global impression of chronic
obstructive pulmonary disease severity, physicians’ re-
sponses were made on the basis of only their personal
deﬁnitions. This ambiguity in language introduces a degree
of random variability, but should not affect the fact that
Table 5 Clinical Factors Associated with Doctors’ Overestimation or Underestimation of Chronic Obstructive Pulmonary Disease Stage
Compared with Spirometry
Clinical Factors
Concordant (N ¼ 202)
Overestimated
Severity (N ¼ 194)
Underestimated
Severity (N ¼ 270)
n Mean (SD) n Mean (SD) n Mean (SD)
Age 202 65.6 (9.9) 194 64.5 (10.7) 270 66.9 (9.7)
Years seeing physician (investigator-reported) 202 9.7 (8.1) 194 9.7 (7.3) 270 10.9 (8.1)
Age at COPD diagnosis (patient-reported) 195 54.2 (15.5) 190 56.1 (13.7) 266 56.7 (13.9)
n Row % n Row % n Row %
Gender
Male 86 27 78 25 152 48
Female 116 33 116 33 118 34
Race/ethnicity*
Non-Hispanic white 163 30 143 27 233 43
Other 38 30 50 40 37 30
Household income*
<$25,000 72 27 94 35 106 39
$25,000-$49,999 55 31 41 23 84 47
$50,000þ 63 34 53 29 70 38
BMI
Underweight (<18.5) 8 29 4 14 16 57
Normal (18.5-24.9) 48 30 31 20 79 50
Overweight (25-29.9) 56 28 47 24 97 49
Obese (BMI 30) 90 32 112 40 78 28
Comorbid conditions
Asthma diagnosis 62 29 70 33 79 37
Other respiratory 56 29 76 40 59 31
Hypertension 139 33 126 30 162 38
Gastrointestinal 63 27 87 37 88 37
Cardiovascular 101 32 105 33 111 35
Mental health 71 28 90 36 91 36
Muscle/bone 97 31 107 34 112 35
Smoking status*
Current smoker 74 30 71 28 105 42
Former smoker 109 31 98 28 149 42
BMI ¼ body mass index; COPD ¼ chronic obstructive pulmonary disease; SD ¼ standard deviation.
*Items do not total 891 responses when some patients did not answer that item.
636 The American Journal of Medicine, Vol 128, No 6, June 2015spirometry did convince many physicians that their patients’
lung function was worse than expected.CONCLUSIONS
This study conﬁrms that spirometry can have a large impact
on how primary care physicians perceive and treat their
patients with chronic obstructive pulmonary disease. We
found that even in patients with chronic obstructive pul-
monary disease who have had relationships with their
physicians for an average of 10 years, spirometry was still
useful. Conversely, without spirometry, patients with
chronic obstructive pulmonary disease have a high proba-
bility of being underestimated or misdiagnosed. The impact
of spirometry on chronic obstructive pulmonary disease
management in this project demonstrates that it is more than
just a test needed for diagnostic completeness; it is ameasure that provides objective information that is essential
for proper evaluation and management in primary care.References
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